Live Breaking News & Updates on பரிசு பெற்றவர் மருந்துகள்
Stay updated with breaking news from பரிசு பெற்றவர் மருந்துகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Genetic Disorders Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Genetic Disorders Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article Government of Canada investments will help advance made-in-Canada vaccines and therapeutics for COVID-19 OTTAWA, ON, March 16, 2021 /CNW/ - Canadians have demonstrated a remarkable ability to mobilize in response to the COVID–19 pandemic. Companies in the biomanufacturing space from coast to coast to coast have answered the call, and the government wants to recognize their work. To date, the Government of Canada has made investments of approximately $1 billion to advance industrial research and development in vaccines and pharmaceuticals, as well as biomanufacturing capacity. We will continue to partner with Canadian industry and businesses to protect Canadians from COVID-19 while building new biomanufacturing capacity as part of our recovery plan. ....
OTTAWA, ON, Dec. 18, 2020 /CNW/ - The Government of Canada is aggressively pursuing the purchase and development of COVID-19 treatments and related supplies to protect Canadians and is working to strengthen Canada s biomanufacturing sector. This includes engaging with Canadian scientists, businesses and manufacturers to build Canada s capacity to fight COVID-19 and future pandemics. Today, the National Research Council of Canada (NRC) announced it is providing advisory services and over $9 million in research and development funding through the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support 4 therapeutic firms. These include: Up to $289,032.00 to Bold Therapeutics (Vancouver, BC) for a project to prepare preclinical efficacy data in live SARS-CoV-2 (COVID-19), support preparation for clinical trials, and to support manufacturing of its BOLD-100 investigational therapy to treat p ....